Endometrial Carcinoma
Conditions
Brief summary
This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Sponsors
Mayo Clinic
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
FEMALE
Age
45 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Self-identified Black individuals ≥ 45 years with an intact uterus * Assigned female sex at birth * Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause) * Willing to participate in a 45-minute virtual interview
Exclusion criteria
* Previous or current diagnosis of endometrial cancer
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Acceptability of vaginal fluid collection for a DNA-based early detection endometrial cancer test | Baseline (30-minute virtual interview) | Information collected during a 30-minute virtual interview using mostly open-ended questions. The interviews will be transcribed and reviewed by the study team to identity themes and create coding categories. Coding categories will be used to organize the data into subthemes. Results will be reported in aggregate. Aggregate results will be disseminated to participants if they elect to receive them. |
Countries
United States
Contacts
CONTACTClinical Trials Referral Office
CONTACTKelly Gunderson
PRINCIPAL_INVESTIGATORShariska Harrington, MD
Mayo Clinic in Rochester
Outcome results
None listed